Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 67,263 | 67,149 | 76,751 | 84,585 | 81,800 |
| Marketable Securities | 29,462 | 29,683 | 30,412 | 11,354 | 3,229 |
| Receivables | 54,643 | 28,105 | 24,584 | 47,837 | 28,974 |
| Inventories | 2,673 | 9,049 | 7,100 | 7,080 | 5,679 |
| Other current assets | 236 | 241 | 255 | 912 | 1,988 |
| TOTAL | $156,817 | $137,720 | $143,026 | $156,185 | $125,354 |
| Non-Current Assets | |||||
| PPE Net | 601 | 680 | 757 | 855 | 907 |
| Intangibles | 53,566 | 56,001 | 58,436 | 60,871 | 63,305 |
| Other Non-Current Assets | 9,737 | 10,601 | 11,930 | 12,617 | 14,039 |
| TOTAL | $63,904 | $67,282 | $71,123 | $74,343 | $78,251 |
| Total Assets | $220,721 | $205,002 | $214,149 | $230,528 | $203,605 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 45,329 | 45,329 | 45,329 | 33,997 | 22,664 |
| Accounts payable and accrued liabilities | 7,509 | 13,500 | 8,964 | 6,889 | 5,061 |
| Accrued Expenses | 50,662 | 39,005 | 37,716 | 52,721 | 33,773 |
| Other current liabilities | 1,550 | 1,303 | 1,205 | 975 | 1,236 |
| TOTAL | $110,397 | $104,296 | $98,191 | $99,382 | $67,362 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,746 | 43,735 | 54,691 | 65,659 | 76,634 |
| Other Non-Current Liabilities | 6,490 | 8,462 | 10,285 | 12,045 | 20,867 |
| TOTAL | $39,236 | $52,197 | $64,976 | $77,704 | $97,501 |
| Total Liabilities | $149,633 | $156,493 | $163,167 | $177,086 | $164,863 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,088 | 49,047 | 48,239 | 48,207 | 47,571 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -1,334,191 | -1,354,508 | -1,349,979 | -1,345,164 | -1,357,432 |
| Other shareholders' equity | 26 | -32 | -26 | -4 | -4 |
| TOTAL | $71,088 | $48,509 | $50,982 | $53,442 | $38,742 |
| Total Liabilities And Equity | $220,721 | $205,002 | $214,149 | $230,528 | $203,605 |